Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 20/20 | 0.63 |
| ▸ | ADORA2A | P29274 | 15/20 | 0.59 |
| ▸ | ADORA1 | P30542 | 15/20 | 0.59 |
| ▸ | ADORA3 | P0DMS8 | 10/20 | 0.54 |
| ▸ | PLK4 | O00444 | 1/20 | 0.52 |
| ▸ | CDK2 | P24941 | 1/20 | 0.52 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.52 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.52 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.52 |
| ▸ | CSNK1G3 | Q9Y6M4 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1724009 | 1.00 | ADORA2B (0.63) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| SCHEMBL1724060 | 0.88 | ADORA2B (0.66) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| SCHEMBL1724457 | 0.86 | ADORA2B (0.63) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| SCHEMBL30891844 | 0.86 | ADORA2B (0.63) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| SCHEMBL2685746 | 0.85 | ADORA2B (0.60) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| SCHEMBL30891848 | 0.85 | ADORA2B (0.60) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| SCHEMBL30891855 | 0.83 | ADORA2B (0.60) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| SCHEMBL2684497 | 0.83 | ADORA2B (0.60) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| SCHEMBL1724465 | 0.80 | ADORA2B (0.71) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| SCHEMBL1946224 | 0.78 | ADORA2B (1.00) | ADORA2BADORA2AADORA1ADORA3PLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118001282-A | Pharmaceutical composition for cancer treatment | 因佩蒂斯生物科学有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-118001282-A | Pharmaceutical composition for cancer treatment | 因佩蒂斯生物科学有限公司 | 2024-05-10 | — | — | CN | disclosed |